Pharmaceuticals

CSL Behring has completed a major restructuring program at its Bern operations, announcing that workforce reductions were lower than originally anticipated despite months of uncertainty surrounding one of Switzerland’s largest pharmaceutical manufacturing sites. The Australian-owned biotechnology company said its transformation initiative has concluded with job losses remaining below ten percent of the local workforce, a…